MCM
MRNA icon

Moore Capital Management’s Moderna MRNA Stock Holding History

Moore Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150,000
Closed -$10M – 581
2024
Q3 		$10M Buy
150,000
+90,000
+150% +$8.26M 0.19% 143
2024
Q2 		$7.13M Hold
60,000
– – 0.12% 164
2024
Q1 		$6.39M Buy
60,000
+33,500
+126% +$3.38M 0.1% 176
2023
Q4 		$2.64M Sell
26,500
-3,500
-12% -$294K 0.05% 208
2023
Q3 		$3.1M Buy
+30,000
New +$3.35M 0.06% 216

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Moore Capital Management's MRNA Position: Q4 2021 in Review

Moore Capital Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 190,000 shares — an estimated $73.1M sold.

Moore Capital Management first reported a position in MRNA in Q3 2021 and held it in 1 quarter. The position peaked at $73.1M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Moore Capital Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Moore Capital Management sold 190,000 Moderna shares in Q4 2021, an estimated $73.1M.
  • Moore Capital Management first reported a position in Moderna in Q3 2021 and held it in 1 quarter.
  • Moore Capital Management's Moderna position peaked at $73.1M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.